TTC8 anticorps (AA 271-533)
Aperçu rapide pour TTC8 anticorps (AA 271-533) (ABIN7873159)
Antigène
Voir toutes TTC8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 271-533
-
Fonction
- BBS8 Antibody / Bardet-Biedl syndrome 8 / TTC8
-
Purification
- Antigen affinity purified
-
Immunogène
- Recombinant human protein (amino acids E271-Q533) was used as the immunogen for the BBS8 antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal dilution of the BBS8 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- After reconstitution, the BBS8 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- TTC8 (Tetratricopeptide Repeat Domain 8 (TTC8))
-
Autre désignation
- BBS8
-
Sujet
- Tetratricopeptide repeat domain 8 (TTC8) also known as Bardet-Biedl syndrome 8 (BBS8) is a protein that in humans is encoded by the TTC8 gene. This gene encodes a protein that has been directly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is involved in the formation of cilia. A mutation in this gene has also been implicated in nonsyndromic retinitis pigmentosa. Alternative splicing results in multiple transcript variants.
-
UniProt
- Q8TAM2
-
Pathways
- Signalisation Hedgehog
Antigène
-